Cortech

Cortechs.ai is a leading healthcare technology company specializing in AI-powered quantitative imaging analysis for neurology and oncology. The company's flagship product, NeuroQuant, is an FDA-cleared software that automates the measurement of brain structures to assist in the diagnosis and monitoring of neurodegenerative diseases such as Alzheimer's and Multiple Sclerosis. Cortechs.ai also offers OnQ Prostate for cancer detection and recently expanded its portfolio into CT imaging through the acquisition of ZepMed. Its solutions are utilized by over 1,400 clinical sites worldwide to provide objective, data-driven insights for precision medicine and clinical trial monitoring.